Items where Author is "El-Sherbiny, Y"

Journal article

ROBINSON, J.I., MD YUSOF, M.Y., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H.J., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, H., VITAL, E.M. and MORGAN, A.W., 2022. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine, 86: 104343. ISSN 2352-3964

YUSOF, M.Y.M., ROBINSON, J.I., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, J.H., VITAL, E.M. and MORGAN, A.W., 2022. OA13 Comprehensive genetic and functional analyses of Fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases. Rheumatology, 61 (S1). ISSN 1462-0332

EL-JAWHARI, J.J., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2021. Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Frontiers in Immunology, 12: 643170. ISSN 1664-3224

ROSS, R., CORINALDESI, C., MIGNECO, G., CARR, I., ANTANAVICIUTE, A., WASSON, C., CARRIERO, A., DISTLER, J., HOLMES, S., EL-SHERBINY, Y., MCKIMMIE, C. and DEL GALDO, F., 2021. Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Annals of the Rheumatic Diseases. ISSN 0003-4967

ZHOU, Q., VADAKEKOLATHU, J., SHARIF, K., RUSSELL, T., ROWE, H., MILLNER, P., LOUGHENBURY, P., RAO, A.S., DUNSMUIR, R., BRIDGEWOOD, C., EL-SHERBINY, Y. and MCGONAGLE, D., 2020. THU0028 an explantion for how viral infection may trigger spondyloarthropathy based on TLR9 driven TNF responses from entheseal derived plasmacytoid dendritic cells. Annals of the Rheumatic Diseases, 79, pp. 227-228. ISSN 0003-4967

EL-JAWHARI, J.J., KLEFTOURIS, G., EL-SHERBINY, Y., SALEEB, H., WEST, R.M., JONES, E. and GIANNOUDIS, P.V., 2019. Defective proliferation and osteogenic potential with altered immunoregulatory phenotype of native bone marrow-multipotential stromal cells in atrophic fracture non-union. Scientific Reports, 9 (1): 17340. ISSN 2045-2322

SELEEM, A.K., AZIZ EL REFAEEY, A., SHAALAN, D., EL-SHERBINY, Y. and BADAWY, A., 2014. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. Journal of Assisted Reproduction and Genetics, 31 (4), pp. 499-504. ISSN 1058-0468

DAS, S., VITAL, E.M., HORTON, S., BRYER, D., EL-SHERBINY, Y., RAWSTRON, A.C., PONCHEL, F., EMERY, P. and BUCH, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967

PONCHEL, F., GOËB, V., PARMAR, R., EL-SHERBINY, Y., BOISSINOT, M., EL JAWHARI, J., BURSKA, A., VITAL, E.M., HARRISON, S., CONAGHAN, P.G., HENSOR, E. and EMERY, P., 2014. An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases, 73 (11), pp. 2047-2053. ISSN 0003-4967

Chapter in book

MD YUSOF, M.Y., ROBINSON, J., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J., EL-SHERBINY, Y., MORRIS, D., LIU, L., RAWSTRON, A., BUCH, M.H., PLANT, D., CORDELL, H., ISAACS, J., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T., BARRETT, J., VITAL, E. and MORGAN, A., 2022. OP0190 Comprehensive genetic and functional analyses of fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases. In: Scientific Abstracts oral presentations. Modern technology for precision medicine. Annals of the Rheumatic Diseases, 81 . BMJ Publishing Group, p. 126.

KOUROUPIS, D., WANG, X.N., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2017. The safety of non-expanded multipotential stromal cell therapies. In: P. VAN PHAM and A. ROSEMANN, eds., Safety, ethics and regulations. Stem cells in clinical applications (SCCA) . Cham: Springer, pp. 91-118. ISBN 9783319591643

Patent/Published patent application

MCGOANGLE, D., JONES, E., EL-SHERBINY, Y. and MOSELEY, T., 2017. Immunomodulation with implantation of cellular allograft bone into a non-bony site. 1202617.